加载中
NYSEHealthcareMedical - Instruments & Supplies
最新数据
US$118.87
−US$0.085 · -0.07%
AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.
常规交易时段
US$119.24
+US$0.29 · +0.24%
盘中时间采用ET。市场数据可能有所延迟。
AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.
日内区间
当前US$119.24
52周区间
当前US$119.24
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
买入
估值
85
深度低估
情绪
60
多空交织
风险
25
中等风险
动量
42
中性
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.
日内区间
当前US$119.24
52周区间
当前US$119.24
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 37.77亿 USD | 35.83亿 USD | 34.87亿 USD | 33.22亿 USD | 32.27亿 USD |
| 销货成本 | 26.6亿 USD | 22.27亿 USD | 22.24亿 USD | 21.58亿 USD | 20.71亿 USD |
| 毛利 | 11.17亿 USD | 13.56亿 USD | 12.63亿 USD | 11.64亿 USD | 11.57亿 USD |
| 研究与开发 | 1.05亿 USD | — | — | — | 9980万 USD |
| 销售、一般及管理费用 | 5亿 USD | 5.82亿 USD | 5.66亿 USD | 5.44亿 USD | 5.51亿 USD |
| 营业费用 | 6.05亿 USD | 8.59亿 USD | 8.59亿 USD | 7.85亿 USD | 8.09亿 USD |
| 利息收入 | 1167.6万 USD | 1210.1万 USD | 437.3万 USD | 270万 USD | 366.8万 USD |
| 利息支出 | 5273.7万 USD | 4389.8万 USD | 4041.8万 USD | 4082.7万 USD | 3028.4万 USD |
| 折旧和摊销 | 2.87亿 USD | 2.64亿 USD | 2.49亿 USD | 2.34亿 USD | 2.35亿 USD |
| 营业利润 | 5.12亿 USD | 4.96亿 USD | 4.04亿 USD | 3.79亿 USD | 3.47亿 USD |
| 净利润 | 3.93亿 USD | 3.75亿 USD | 2.84亿 USD | 2.39亿 USD | 2.44亿 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI2.67亿0.01%2.3万亿 USD0.03%US$381.08-0.13%
Vanguard Morningstar Small-Cap ETFVB1.93亿0.10%1853亿 USD0.03%US$287.31-0.30%
Vanguard Morningstar Small-Cap Value ETFVBR1.23亿0.18%682亿 USD0.05%US$234.37-0.14%
Vanguard Extended Market ETFVXF9761.06万0.10%954亿 USD0.05%US$232.37-0.49%
Dimensional - US Targeted Value ETFDFAT7251.45万0.24%302.16亿 USD0.33%US$67.44+0.03%
State Street SPDR S&P Dividend ETFSDY6801.62万0.33%206.92亿 USD0.35%US$150.07-0.21%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY5708.52万0.22%258.17亿 USD0.23%US$665.49-0.27%
Vanguard Dividend Appreciation ETFVIG4754.8万0.04%1324亿 USD0.04%US$239.64-0.17%Vanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Value ETFVBRVanguard Extended Market ETFVXFDimensional - US Targeted Value ETFDFATState Street SPDR S&P Dividend ETFSDYState Street SPDR S&P MIDCAP 400 ETF TrustMDYVanguard Dividend Appreciation ETFVIGAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
